These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A cost containment tool for antibiotics. Judd C; Moist L; Rose C; Gopaul D Dimens Health Serv; 1989 Nov; 66(8):25-6. PubMed ID: 2606294 [No Abstract] [Full Text] [Related]
8. Cost reductions for IV antibiotics in a 150-bed hospital. Baughman TL QRB Qual Rev Bull; 1984 Feb; 10(2):41-4. PubMed ID: 6424077 [No Abstract] [Full Text] [Related]
9. Cost containment measures in hospital pharmacy: a bibliography. Treleaven S; Einarson TR Can J Hosp Pharm; 1990 Feb; 43(1):17-25. PubMed ID: 10106452 [TBL] [Abstract][Full Text] [Related]
10. Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost. Climo MW; Israel DS; Wong ES; Williams D; Coudron P; Markowitz SM Ann Intern Med; 1998 Jun; 128(12 Pt 1):989-95. PubMed ID: 9625685 [TBL] [Abstract][Full Text] [Related]
11. The effects of DRGs and cost-containment: assessment by hospital pharmacy directors. McGhan WF; Larson LN; Raisch DW Hosp Formul; 1986 Aug; 21(8):870-1, 874-6. PubMed ID: 10311626 [TBL] [Abstract][Full Text] [Related]
12. Hospital cost containment and the pharmacist. Zellmer WA Am J Hosp Pharm; 1979 Jan; 36(1):31. PubMed ID: 758782 [No Abstract] [Full Text] [Related]
15. Two approaches to cost containment in hospital pharmacy. Strand LM; Morley PC Am J Hosp Pharm; 1985 Apr; 42(4):852-6. PubMed ID: 4014239 [No Abstract] [Full Text] [Related]
16. Impact of a target drug monitoring program on the usage of clindamycin. Gin AS; Lipinski LA; Honcharik N Can J Hosp Pharm; 1994 Apr; 47(2):53-8. PubMed ID: 10134127 [TBL] [Abstract][Full Text] [Related]
17. Cost analysis of mixing clindamycin and aminoglycosides. Abel SR; Olson SM Am J Hosp Pharm; 1987 Jun; 44(6):1385-7. PubMed ID: 3618617 [TBL] [Abstract][Full Text] [Related]